Literature DB >> 6114321

Treatment of ulcerative colitis with high-dose 5-aminosalicylic acid enemas.

M Campieri, G A Lanfranchi, G Bazzocchi, C Brignola, F Sarti, G Franzin, A Battocchia, G Labo, P R Dal Monte.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 6114321     DOI： 10.1016/s0140-6736(81)90523-7

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  60 in total

Review 1.  Drug therapy of ulcerative colitis.

Authors:  B Crotty; D P Jewell
Journal:  Br J Clin Pharmacol       Date:  1992-09       Impact factor: 4.335

2.  Inflammatory bowel disease in Korea: epidemiological, genomic, clinical, and therapeutic characteristics.

Authors:  Eun Soo Kim; Won Ho Kim
Journal:  Gut Liver       Date:  2010-03-25       Impact factor: 4.519

Review 3.  Inflammatory intermediaries in inflammatory bowel disease.

Authors:  K Lauritsen; L S Laursen; K Bukhave; J Rask-Madsen
Journal:  Int J Colorectal Dis       Date:  1989       Impact factor: 2.571

4.  Double blind, controlled trial of 4-aminosalicylic acid and prednisolone enemas in distal ulcerative colitis.

Authors:  L J O'Donnell; A S Arvind; P Hoang; D Cameron; I C Talbot; D P Jewell; J E Lennard-Jones; M J Farthing
Journal:  Gut       Date:  1992-07       Impact factor: 23.059

5.  Placebo-controlled trial of oral 5-ASA in relapse prevention of Crohn's disease.

Authors:  C Brignola; P Iannone; S Pasquali; M Campieri; P Gionchetti; A Belluzzi; O Basso; M Miglioli; L Barbara
Journal:  Dig Dis Sci       Date:  1992-01       Impact factor: 3.199

Review 6.  Clinical pharmacokinetics of drugs used in the treatment of gastrointestinal diseases (Part II).

Authors:  K Lauritsen; L S Laursen; J Rask-Madsen
Journal:  Clin Pharmacokinet       Date:  1990-08       Impact factor: 6.447

Review 7.  Hypersensitivity to 5-ASA suppositories.

Authors:  M L Borum; A Ginsberg
Journal:  Dig Dis Sci       Date:  1997-05       Impact factor: 3.199

Review 8.  Clinical pharmacokinetics of sulphasalazine, its metabolites and other prodrugs of 5-aminosalicylic acid.

Authors:  U Klotz
Journal:  Clin Pharmacokinet       Date:  1985 Jul-Aug       Impact factor: 6.447

9.  Topical administration of 5-aminosalicylic acid enemas in patients with ulcerative colitis. Studies on rectal absorption and excretion.

Authors:  M Campieri; G A Lanfranchi; S Boschi; C Brignola; G Bazzocchi; P Gionchetti; M R Minguzzi; A Belluzzi; G Labò
Journal:  Gut       Date:  1985-04       Impact factor: 23.059

10.  Better quality of therapy with 5-ASA colonic foam in active ulcerative colitis. A multicenter comparative trial with 5-ASA enema.

Authors:  M Campieri; P Paoluzi; G D'Albasio; G Brunetti; A Pera; L Barbara
Journal:  Dig Dis Sci       Date:  1993-10       Impact factor: 3.199
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.